Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
SS Innovations International ( (SSII) ) just unveiled an update.
On April 7, 2026, SS Innovations International announced it would host the Global Multi-Specialty Robotic Surgery Conference (SMRSC 2026) in New Delhi, India, from April 9–11, 2026, bringing together surgeons, innovators and healthcare leaders to discuss the future of robotic and minimally invasive surgery. The third edition of the conference is set to feature more than 20 live telesurgeries using the SSi Mantra system and its portable MantrAsana tele-surgeon console, as well as demonstrations of the in-development SSi Vimana Aero drone-based trauma surgery platform, the mobile Project Operion “operating room of the future,” and the MantraM bus telesurgery unit, underscoring the company’s push to decentralize high-end surgical care, extend training beyond hospitals and strengthen its position in affordable, remote robotic surgery solutions.
Multispecialty and cardiac-focused sessions, along with participation from high-profile surgeons and dignitaries including SS Innovations vice-chairman and robotic surgery pioneer Dr. Fred Moll, are expected to expand on last year’s attendance of over 1,400 in-person and 600 virtual participants. By showcasing a broad ecosystem of telesurgery-enabling technologies aimed at underserved and remote settings, the event highlights SS Innovations’ strategic emphasis on mobile, connected robotic platforms that could influence standards of care and attract interest from clinicians, healthcare systems and defense stakeholders focused on battlefield and rural medicine.
The most recent analyst rating on (SSII) stock is a Hold with a $5.00 price target. To see the full list of analyst forecasts on SS Innovations International stock, see the SSII Stock Forecast page.
Spark’s Take on SSII Stock
According to Spark, TipRanks’ AI Analyst, SSII is a Neutral.
The score is held back primarily by weak profitability and worsening cash burn despite strong revenue growth and an improved balance sheet. Technicals are modestly constructive in the near term, while valuation is constrained by ongoing losses and no dividend. Positive corporate events (approvals and new capital) improve the outlook but do not fully offset financial execution risk.
To see Spark’s full report on SSII stock, click here.
More about SS Innovations International
SS Innovations International, Inc. is a surgical robotics company that develops technologically advanced, user-friendly and cost-effective systems aimed at making robotic surgery affordable and accessible globally. Its portfolio centers on the SSi Mantra multi-arm robotic surgical platform and SSi Mudra instruments, supporting multi-specialty and cardiac procedures, and the company is headquartered in India while listed on Nasdaq.
Average Trading Volume: 93,685
Technical Sentiment Signal: Sell
Current Market Cap: $963.1M
Find detailed analytics on SSII stock on TipRanks’ Stock Analysis page.